Fig. 4.

Few predicted multi-allele binding epitopes from individual SARS-CoV-2 proteins can achieve broad population coverage. a Cumulative HLA-I coverage for USA, EUR, and API populations versus the number of included prioritized HLA-I epitopes for M, N, and S proteins, respectively. See Additional file 5: Table S5 for the peptide sequences corresponding to each panel. b Cumulative HLA-II coverage for each population versus the number of included prioritized HLA-II 25mers for M, N, and S proteins, respectively. See Additional file 7: Table S7 for the peptide sequences corresponding to each panel